Trichomoniasis risk factors: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
{{Trichomoniasis}} | {{Trichomoniasis}} | ||
{{CMG}} {{AE}} {{Maliha}} | {{CMG}}; {{AE}} {{Maliha}} | ||
==Overview== | ==Overview== | ||
Line 16: | Line 16: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gynecology]] | |||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] |
Latest revision as of 00:29, 30 July 2020
Trichomoniasis Microchapters |
Diagnosis |
Treatment |
Case Studies |
Trichomoniasis risk factors On the Web |
American Roentgen Ray Society Images of Trichomoniasis risk factors |
Risk calculators and risk factors for Trichomoniasis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2]
Overview
Common risk factors in the development of trichomoniasis include multiple sexual partners, unprotected sexual activity, intravenous drug use, and coexisting veneral disease.[1][2]
Risk Factors
Common risk factors in the development of trichomoniasis include:[1][2]
- Multiple sexual partners
- Unprotected sexual activity
- Co-existing venereal diseases
- Intravenous drug use
References
- ↑ 1.0 1.1 "Trichomoniasis - CDC Fact Sheet". Retrieved 12 January 2011.
- ↑ 2.0 2.1 Kissinger P (2015). "Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues". BMC Infect Dis. 15: 307. doi:10.1186/s12879-015-1055-0. PMC 4525749. PMID 26242185.